Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. VINGE ADVISES VOSTOK EMERGING FINANCE IN CONNECTION WITH A RIGHTS ISSUE
Mandate

VINGE ADVISES VOSTOK EMERGING FINANCE IN CONNECTION WITH A RIGHTS ISSUE

December 08, 2015

Vinge advises Vostok Emerging Finance Ltd and Pareto Securities AB in connection with an approx. SEK 588 million rights issue in Vostok Emerging Finance.

Vostok Emerging Finance is an investment company with the goal of investing in early stage modern financial services companies across emerging and frontier markets.

Vinge’s team primarily consisted of Jesper Schönbeck, Joakim Hagberg, Sabina Börjesson, Joel Wahlberg, Amanda Knutsson and Malte Hedlund

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026